Athersys Inc (NASDAQ:ATHX)

2.04
Delayed Data
As of Jun 22
 +0.08 / +4.08%
Today’s Change
1.29
Today|||52-Week Range
3.09
+12.71%
Year-to-Date
Athersys Enters Oversold Territory
Jun 22 / Zacks.com - Paid Partner Content
Top Ranked Momentum Stocks to Buy for June 12th
Jun 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.96
Today’s open1.97
Day’s range1.91 - 2.07
Volume2,620,489
Average volume (3 months)855,712
Market cap$304.9M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-61.11%
Earnings growth (this year)+20.69%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-78.62%
P/E ratioNM
Price/Sales54.70
Price/Book11.54

Competitors

 Today’s
change
Today’s
% change
NYMXNymox Pharmaceutical...+0.64+19.69%
OBSVObseva SA-0.22-1.47%
NLNKNewLink Genetics Cor...-0.06-1.16%
MNOVMediciNova Inc+0.05+0.58%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)$0.00
Annual revenue (last year)$3.7M
Annual profit (last year)-$32.2M
Net profit margin-869.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Gil van Bokkelen
President, Chief Operating Officer &
Secretary
William B. J. Lehmann
Corporate headquarters
Cleveland, Ohio

Forecasts